MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy

Guo-Hua Gong; Feng-Mao An; Yu Wang; Ming Bian; Di Wang; Cheng-Xi Wei

doi:10.18632/oncotarget.24012

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression of Concern

This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.

MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy

Guo-Hua Gong _, Feng-Mao An, Yu Wang, Ming Bian, Di Wang and Cheng-Xi Wei

PDF | HTML | How to cite

Oncotarget. 2018; 9:8542-8547. https://doi.org/10.18632/oncotarget.24012

Metrics: PDF 1331 views | HTML 1972 views | ?

Abstract

Guo-Hua Gong1,2,3,*, Feng-Mao An1,2,*, Yu Wang1,2, Ming Bian1,2, Di Wang1,2 and Cheng-Xi Wei1,2

1Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia, P.R. China

2Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia, P.R. China

3First Clinical Medical of Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia, P.R. China

*These authors contributed equally to this work

Correspondence to:

Cheng-Xi Wei, email: [email protected]

Keywords: epilepsy; mTLE; miR-153; HIF-1α; luciferase reporter assay

Received: September 16, 2017 Accepted: November 13, 2017 Published: January 05, 2018

ABSTRACT

Mesial temporal lobe epilepsy (mTLE), the most common type of temporal lobe epilepsy (TLE), is particularly relevant due to its high frequency of therapeutic resistance of anti-epileptic therapies. MicroRNAs (miRNAs) have been shown to be dysregulated in epilepsy and neurodegenerative diseases, and we hypothesized that miRNAs could be involved in the pathogenesis of MTLE. The present study aimed to explore the expression and functions of miRNA-153 in mTLE. The expression levels of miRNA-153 in refractory TLE patients were evaluated. The bioinformatics analysis showed that the potential target genes of miR-153 were involved in biological processes, molecular functions, and cellular components. miRNA-153 is significantly dysregulated in temporal cortex and plasma of mTLE patients. We identify HIF-1α as a direct target of miRNA-153, and luciferase reporter assays demonstrated that miR-153 could regulate the HIF-1αexpression via 3'-UTR pairing. These data suggest that miR-153 might represent a useful biomarker and treatment target for patients with mTLE.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24012

Publication Alerts

Research Papers:

MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy

Abstract